hotspot -WSS

hotspot

author：knowledge 2025-09-27 22:18:28 - browse：385

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Recent heat wave in the Mediterranean caused by climate change: Study

leisure time

WSS

Home health providers sue Medicare over payment cuts

Microbiome research is starting to find links to chronic diseases

ACA's risk program benefits Blue Cross Blue Shield insurers

FDA panel to weigh approval of NurOwn, controversial ALS drug

Readout LOUD podcast: possible new ALS drug, artificial wombs

Intarcia’s device

leisure time

hotspot

explore

Tori Bowie and the unacceptable rates of Black maternal death

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Medicare details structure of new drug price negotiation program

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

In age of alternative facts, a scholarly course on calling out crap

CDC's new outbreak response network to include Northeastern

Medical records are filled with copy

EpiPen alternative approval delay highlights citizen petition issue

DIEP, the 'gold standard' of breast reconstruction, is under threat

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

entertainment

Hearing on Medicare drug price negotiation gets unusually heated

Create a giant ice tray with this foil pan hack to keep food cold this summer

Experts study whether long Covid risk adds up with each reinfection

Why are Kaiser Permanente staff considering a strike?

Eisai exec who led development of Alzheimer’s drug to retire

Experts study whether long Covid risk adds up with each reinfection

leisure time

knowledge

leisure time

focus